Eastman Chemical Company EMN will raise the list and off-list selling prices of Choline Chloride by 4 cents per lb in North America. The price hike will be effective from Apr 1 or as contracts permit.
Eastman Chemical is taking appropriate pricing actions amid an escalated raw material pricing environment. High selling prices drove revenues in the company’s Chemical Intermediates segment in fourth-quarter 2017.
In the fourth quarter, Eastman Chemical’s reported earnings of $ 1.62 per share, up from $ 1.51 in the year ago-quarter. The results surpassed the Zacks Consensus Estimate of $ 1.06. Revenues rose around 8% year over year to $ 2,362 million, outpacing the Zacks Consensus Estimate of $ 2,289.5 million.
Eastman Chemical’s shares have moved up 43.4% over a year, outperforming the 20.4% gain of the industry it belongs to.
In 2018, the company expects to drive growth on the back of investments, innovation and high margin products. A modestly lower tax rate will support earnings growth in 2018. Eastman Chemical anticipates raw material and energy prices, especially for olefins, to be volatile this year. Eastman Chemical thus remains focused on cost-cutting and productivity actions, which will likely help it to offset raw material cost inflation and other cost headwinds. The company expects to deliver $ 100 million of cost savings in 2018 under its cost-reduction program. Its cost-reduction actions are expected to contribute to its earnings per share in 2018. The company expects adjusted EPS growth in 2018 to be 8-12% year over year.
The company should also gain from its strategic acquisitions, especially Taminco. Further, it remains committed to reduce debt and boost shareholder returns leveraging strong free cash flows. Eastman Chemical returned more than $ 646 million to shareholders during 2017..
Eastman Chemical Company Price and Consensus
Zacks Rank & Other Stocks to Consider
Eastman Chemical has a Zacks Rank #2 (Buy).
LyondellBasell has an expected long-term earnings growth rate of 9% and sports a Zacks Rank #1 (Strong Buy). The company’s shares have moved up 23.2% in a year. You can see the complete list of today’s Zacks #1 Rank stocks here.
Cabot has an expected long-term earnings growth rate of 10% and flaunts a Zacks Rank #1. The company’s shares have moved up 5.5% in a year.
Methanex has an expected long-term earnings growth rate of 15% and carries a Zacks Rank #2. Its shares have gained 19.3% over a year.
Zacks Top 10 Stocks for 2018
In addition to the stocks discussed above, would you like to know about our 10 finest buy-and-hold tickers for the entirety of 2018?
Last year's 2017 Zacks Top 10 Stocks portfolio produced double-digit winners, including FMC Corp. and VMware which racked up stellar gains of +67.9% and +61%. Now a brand-new portfolio has been handpicked from over 4,000 companies covered by the Zacks Rank. Don’t miss your chance to get in on these long-term buys.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Eastman Chemical Company (EMN): Free Stock Analysis Report
Methanex Corporation (MEOH): Free Stock Analysis Report
Cabot Corporation (CBT): Free Stock Analysis Report
LyondellBasell Industries N.V. (LYB): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
Zacks Investment Research – All Commentary Articles